Disclosed positions

Estimated from their latest filings — positions may have changed since

$25.42M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ALGNALIGN TECHNOLOGY INC	135,916	$185.22	$25.17M	99%	2026-05-20
NPCENeuroPace Inc	13,889	$17.80	$247.2K	1%	2025-12-19

ALGN

ALIGN TECHNOLOGY INC

$25.17M

135,916 sh

NPCE

NeuroPace Inc

$247.2K

13,889 sh

All filings on record

Every Form 4 transaction we track for this filer

all 12buys 0sells 0

Stock	Transaction	Date	~6mo later
ALGNALIGN TECHNOLOGY INC	Exercise — · 1,745 sh	2026-05-20	—
NPCENeuroPace Inc	Grant $11.2K · 678 sh	2025-12-19	—
NPCENeuroPace Inc	Grant $11.2K · 1,131 sh	2025-09-19	—
NPCENeuroPace Inc	Grant $11.2K · 1,080 sh	2025-06-21	—
NPCENeuroPace Inc	Grant $11.2K · 935 sh	2025-03-21	—
NPCENeuroPace Inc	Grant $11.2K · 975 sh	2024-12-21	—
NPCENeuroPace Inc	Grant $11.2K · 1,614 sh	2024-09-30	—
NPCENeuroPace Inc	Grant $11.2K · 1,488 sh	2024-06-28	—
NPCENeuroPace Inc	Grant $11.2K · 852 sh	2024-03-29	—
NPCENeuroPace Inc	Grant $11.2K · 1,091 sh	2023-12-29	—
NPCENeuroPace Inc	Grant $11.2K · 1,156 sh	2023-09-29	—
NPCENeuroPace Inc	Grant $11.2K · 2,505 sh	2023-06-30	—

ALGNExercise

2026-05-20 · ALIGN TECHNOLOGY INC

1,745

—

NPCEGrant

2025-12-19 · NeuroPace Inc

$11.2K

—

NPCEGrant

2025-09-19 · NeuroPace Inc

$11.2K

—

NPCEGrant

2025-06-21 · NeuroPace Inc

$11.2K

—

NPCEGrant

2025-03-21 · NeuroPace Inc

$11.2K

—

NPCEGrant

2024-12-21 · NeuroPace Inc

$11.2K

—

NPCEGrant

2024-09-30 · NeuroPace Inc

$11.2K

—

NPCEGrant

2024-06-28 · NeuroPace Inc

$11.2K

—

NPCEGrant

2024-03-29 · NeuroPace Inc

$11.2K

—

NPCEGrant

2023-12-29 · NeuroPace Inc

$11.2K

—

NPCEGrant

2023-09-29 · NeuroPace Inc

$11.2K

—

NPCEGrant

2023-06-30 · NeuroPace Inc

$11.2K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.